Showing results (541-550 of 785) with videos related to

Sort By:
Pageof 79
Gastrointestinal Endoscopy|January 9, 2018
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel diseaseNoa Krugliak Cleveland, Dezheng Huo, Farah Sadiq, et al.
Archives of General Psychiatry|May 1, 1988
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatmentI M Lesser, R T Rubin, J C Pecknold, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2007
Adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low-magnitude mechanical signalsC T Rubin, E Capilla, Y K Luu, et al.
Journal of Affective Disorders|January 1, 1989
Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatmentI M Lesser, R T Rubin, A Rifkin, et al.
Archives of General Psychiatry|June 1, 1980
beta-Endorphin and schizophreniaP A Berger, S J Watson, H Akil, et al.
The American Journal of Gastroenterology|October 16, 2008
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trialEdward V Loftus, Brian G Feagan, Jean-Frédéric Colombel, et al.
JCO Oncology Practice|May 15, 2025
Low-Intensity Vibration to Reduce Symptoms and Improve Physical Functioning in Cancer Survivors With Chemotherapy-Induced Peripheral Neuropathy: A Pilot Randomized TrialStephanie M Krasnow, Clinton T Rubin, Eric J Roeland, et al.
Inflammatory Bowel Diseases|October 15, 2020
Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and PhysiciansDavid T Rubin, Ailsa Hart, Remo Panaccione, et al.
Journal of Neurosurgery|August 1, 1989
The effect of intravenous interleukin-2 on brain water contentS C Saris, N J Patronas, S A Rosenberg, et al.
Journal of Crohn'S & Colitis|February 7, 2019
Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel DiseasesAnthony Buisson, Wing Yan Mak, Michael J Andersen, et al.
Pageof 79